NO158343C - Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater. - Google Patents

Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater.

Info

Publication number
NO158343C
NO158343C NO831901A NO831901A NO158343C NO 158343 C NO158343 C NO 158343C NO 831901 A NO831901 A NO 831901A NO 831901 A NO831901 A NO 831901A NO 158343 C NO158343 C NO 158343C
Authority
NO
Norway
Prior art keywords
ureidocyclohexylamino
propan
preparation
therapeutic active
diol derivatives
Prior art date
Application number
NO831901A
Other languages
English (en)
Norwegian (no)
Other versions
NO831901L (no
NO158343B (no
Inventor
Lincoln Harvey Werner
Neville Ford
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO831901L publication Critical patent/NO831901L/no
Publication of NO158343B publication Critical patent/NO158343B/no
Publication of NO158343C publication Critical patent/NO158343C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/26Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/40Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/36One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO831901A 1982-05-28 1983-05-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater. NO158343C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38304982A 1982-05-28 1982-05-28

Publications (3)

Publication Number Publication Date
NO831901L NO831901L (no) 1983-11-29
NO158343B NO158343B (no) 1988-05-16
NO158343C true NO158343C (no) 1988-08-24

Family

ID=23511486

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831901A NO158343C (no) 1982-05-28 1983-05-27 Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater.

Country Status (16)

Country Link
EP (1) EP0096006A3 (fr)
JP (1) JPS5931753A (fr)
KR (1) KR840004729A (fr)
AU (1) AU559970B2 (fr)
CA (1) CA1215711A (fr)
DD (1) DD210266A5 (fr)
DK (1) DK238083A (fr)
ES (4) ES8604887A1 (fr)
FI (1) FI831863L (fr)
GR (1) GR79228B (fr)
IL (1) IL68794A0 (fr)
NO (1) NO158343C (fr)
NZ (1) NZ204383A (fr)
PH (1) PH20374A (fr)
PT (1) PT76772B (fr)
ZA (1) ZA833861B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722983A (en) * 1985-12-13 1988-02-02 Ciba-Geigy Corporation Process for the preparation of glycidyl compounds
SE9802208D0 (sv) * 1998-06-22 1998-06-22 Astra Pharma Inc Novel compounds
CZ2003106A3 (cs) * 2000-07-13 2003-04-16 Eli Lilly And Company Agonisté adrenergního beta-3 receptoru
US8013156B2 (en) 2003-03-19 2011-09-06 Exelixis, Inc. Tie-2 modulators and methods of use
FR2935141B1 (fr) * 2008-08-21 2010-10-08 Sanofi Aventis Procede de preparation de l'ester ethylique de l'acide 4-[trans-4-[(phenylmethyl)-amino]cyclohexyl]benzoique et de son sel hemifumarate

Also Published As

Publication number Publication date
NO831901L (no) 1983-11-29
ES8607943A1 (es) 1986-06-01
ES535964A0 (es) 1986-06-01
ES8607942A1 (es) 1986-06-01
AU559970B2 (en) 1987-03-26
ES535965A0 (es) 1986-06-01
DK238083D0 (da) 1983-05-27
ES8608492A1 (es) 1986-06-16
EP0096006A2 (fr) 1983-12-07
ES535963A0 (es) 1986-06-16
PH20374A (en) 1986-12-08
EP0096006A3 (fr) 1984-12-19
FI831863L (fi) 1983-11-29
PT76772A (en) 1983-06-01
ES522723A0 (es) 1986-02-16
DD210266A5 (de) 1984-06-06
CA1215711A (fr) 1986-12-23
DK238083A (da) 1983-11-29
ES8604887A1 (es) 1986-02-16
GR79228B (fr) 1984-10-22
ZA833861B (en) 1984-02-29
NO158343B (no) 1988-05-16
IL68794A0 (en) 1983-09-30
KR840004729A (ko) 1984-10-24
NZ204383A (en) 1985-12-13
PT76772B (en) 1986-03-27
FI831863A0 (fi) 1983-05-25
JPS5931753A (ja) 1984-02-20
AU1520183A (en) 1983-12-01

Similar Documents

Publication Publication Date Title
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO156785C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cyklobutan-derivater.
NO810765L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive karbostyrilderivater.
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO157102C (no) AnalogifremgangsmŸte til fremstilling av terapeutisk aktivt 3-(2-morfolinoetylamino)-5-fenylpyridazin.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
NO164168C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser.
NO155665C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5,6,7,7a-tetrahydro-4h-thieno-(3,2-c)-pyridin-2-on-derivater.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO148644C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive sukkerderivater.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO159090C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO158343C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(ureidocykloheksylamino)-propan-1,2-diol-derivater.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.
NO154052C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolon-derivater.
NO811360L (no) Fremgangsmaate for fremstilling av terapeutisk aktivt hydratisert picotamid.